Daniel F. Cain
Directeur Général chez Wireless Medical, Inc.
Profil
Daniel F.
Cain is currently the Chief Executive Officer at Wireless Medical, Inc. He previously worked as an Independent Director at Repros Therapeutics, Inc. from 2004 to 2018.
He holds an MBA from Indiana University and an undergraduate degree from Letourneau College.
Postes actifs de Daniel F. Cain
Sociétés | Poste | Début |
---|---|---|
Wireless Medical, Inc. | Directeur Général | 01/05/2000 |
Anciens postes connus de Daniel F. Cain
Sociétés | Poste | Fin |
---|---|---|
REPROS THERAPEUTICS INC | Directeur/Membre du Conseil | 31/01/2018 |
Formation de Daniel F. Cain
Indiana University | Masters Business Admin |
Letourneau College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Repros Therapeutics, Inc.
Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Wireless Medical, Inc. |